LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

Search

ADMA Biologics Inc

Fermé

Secteur Soins de santé

12.76 3.66

Résumé

Variation du prix de l'action

24h

Actuel

Min

12.66

Max

12.79

Chiffres clés

By Trading Economics

Revenu

35M

18M

Ventes

8M

82M

BPA

0.08

Marge bénéficiaire

21.748

Employés

624

EBITDA

7.9M

24M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

-4.15 downside

Dividendes

By Dow Jones

Prochains Résultats

7 août 2024

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

95M

2.7B

Ouverture précédente

9.1

Clôture précédente

12.76

Sentiment de l'Actualité

By Acuity

50%

50%

117 / 369 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Weak Bearish Evidence

ADMA Biologics Inc Graphique

Actualités Associées

12 juil. 2024, 22:05 UTC

Acquisitions, Fusions, Rachats

Pactiv Evergreen Sells Paper Mill, Extrusion Facility to Suzano for $110 Million

12 juil. 2024, 20:18 UTC

Acquisitions, Fusions, Rachats

Lundin Mining Approaches BHP to Buy Copper Miner Filo, Bloomberg Reports

12 juil. 2024, 19:57 UTC

Principaux Mouvements du Marché

Instil Bio Shares Surge Following Rental Agreement with AstraZeneca

12 juil. 2024, 18:13 UTC

Actualités

Elon Musk's X Found in Breach of EU Digital-Content Law -- 2nd Update

12 juil. 2024, 23:29 UTC

Acquisitions, Fusions, Rachats

BP Says Oil Demand Is Falling, While OPEC Says It's Rising. What Gives? -- Barrons.com

12 juil. 2024, 21:50 UTC

Acquisitions, Fusions, Rachats

Pactiv Evergreen Sells Paper Mill, Extrusion Facility to Suzano for $110M

12 juil. 2024, 21:03 UTC

Actualités
Acquisitions, Fusions, Rachats

The Score: Microsoft, Delta Air Lines, Wells Fargo and More Stocks That Defined the Week -- WSJ

12 juil. 2024, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

12 juil. 2024, 20:41 UTC

Actualités

Dow Rises With Investors Putting Rate Cut in Sight -- WSJ

12 juil. 2024, 20:38 UTC

Acquisitions, Fusions, Rachats

Ansys: Synopsys Submits Notification of Transaction to China Regulator for Purchase of Ansys

12 juil. 2024, 20:26 UTC

Actualités
Résultats

Big Banks Continue to Feel Pressure From Higher Rates -- 3rd Update

12 juil. 2024, 20:19 UTC

Résultats

These Stocks Moved the Most Today: Tesla, Wells Fargo, JPMorgan, BNY, Nvidia, and More -- Barrons.com

12 juil. 2024, 19:26 UTC

Résultats

Correction to Big Banks Continue to Feel Pressure From Higher Rates Article -- WSJ

12 juil. 2024, 19:07 UTC

Market Talk

U.S. Natural Gas Futures Snap 3-Day Losing Streak -- Market Talk

12 juil. 2024, 17:52 UTC

Actualités
Résultats

Big Banks Continue to Feel Pressure From Higher Rates -- 3rd Update

12 juil. 2024, 17:34 UTC

Market Talk

Gold Takes Pause After Surge -- Market Talk

12 juil. 2024, 17:31 UTC

Market Talk

U.S. Oil Rig Count Down By 1 to 478 -- Market Talk

12 juil. 2024, 17:22 UTC

Market Talk

Private-Capital Investing For Solar Developers Dropped in 1H -- Market Talk

12 juil. 2024, 17:01 UTC

Actualités

AT&T Says Hacker Stole Cell, Text Data on Nearly All Its Wireless Customers -- 2nd Update

12 juil. 2024, 16:45 UTC

Market Talk

Nike's Corporate Plan Step in Right Direction, but Challenges Mount -- Market Talk

12 juil. 2024, 16:44 UTC

Market Talk

Estée Lauder CFO Change Needs to Offer Fresh Perspective -- Market Talk

12 juil. 2024, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

12 juil. 2024, 16:08 UTC

Market Talk

Gold Futures Pare Some Gains But Hold Above $2,400 on Soft Inflation Data -- Market Talk

12 juil. 2024, 16:02 UTC

Actualités

Big Banks Continue to Feel Pressure From Higher Rates -- 2nd Update

12 juil. 2024, 15:45 UTC

Market Talk

KC Fed Seeing Green Shoots in Energy Activity -- Market Talk

12 juil. 2024, 15:43 UTC

Market Talk

Bank of Canada Likely Thrilled With Housing-Market Data -- Market Talk

12 juil. 2024, 15:39 UTC

Market Talk

Canada Home-Sales Activity 'Subdued' Despite Rise in June -- Market Talk

12 juil. 2024, 15:36 UTC

Actualités

Berkshire Hathaway Stock Hits Record. Warren Buffett's Stake at $133 Billion. -- Barrons.com

12 juil. 2024, 15:32 UTC

Actualités

AT&T Says Hacker Stole Cell, Text Data on Nearly All Its Wireless Customers -- Update

12 juil. 2024, 15:32 UTC

Market Talk

Boeing Profits Lost In Space -- Market Talk

Comparaison

Variation de prix

ADMA Biologics Inc prévision

Objectif de Prix

By TipRanks

-4.15% baisse

Prévisions sur 12 Mois

Moyen 12.25 USD  -4.15%

Haut 15 USD

Bas 10 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

4 ratings

4

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

11.18 / N/ASupport & Résistance

Court Terme

Weak Bearish Evidence

Moyen Terme

No Evidence

Long Terme

Weak Bullish Evidence

Sentiment

By Acuity

117 / 369Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos ADMA Biologics Inc

ADMA Biologics, Inc. is a biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The Company is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its segments include ADMA BioManufacturing and Plasma Collection Centers. The Company’s ADMA BioManufacturing segment reflects its immune globulin manufacturing and development operations in Florida. The Plasma Collection Centers segment consists of approximately three plasma collection facilities. Its products include BIVIGAM, ASCENIV and Nabi-HB. Its product candidates are intended to be used by physician specialists focused on caring for immune-compromised patients at risk of contracting infectious diseases. Its targeted patient populations are immune-compromised individuals suffering from an underlying immune deficiency disorder or may be immune-suppressed for medical reasons.